<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03565640</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00051211</org_study_id>
    <nct_id>NCT03565640</nct_id>
  </id_info>
  <brief_title>Anchorsure Versus Capio for Sacrospinous Ligament Fixation</brief_title>
  <official_title>Randomized Trial Comparing Anchorsure® Suture Anchoring System and the CapioTM Slim Suture Capturing Device for Sacrospinous Ligament Suspension.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sacrospinous ligament fixation is a common method of repairing apical support for pelvic
      organ prolapse but it currently suffers from a high rate of postoperative buttock and
      posterior thigh pain. Anchorsure® is a relatively new FDA-approved device that uses an anchor
      instead of the widely-used suture capturing mechanism to perform sacrospinous ligament
      fixation. The study hypothesis is that Anchorsure® will reduce the degree and rate of buttock
      and posterior thigh pain compared to the widely used Capio™ Slim suturing capturing Device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sacrospinous ligament fixation is a common method of repairing apical support for pelvic
      organ prolapse but it currently suffers from a high rate of postoperative buttock and
      posterior thigh pain. Rates of buttock and thigh pain 6 weeks after sacrospinous ligament
      fixation with the widely used Capio™ Slim device (Boston Scientific) are about 15-16% with
      immediate postoperative pain occurring in 55-84% of patients. This study is a randomized
      controlled single-blind study with the primary goal of investigating if there is an
      improvement in the intensity and rate of buttock and posterior thigh pain 1 day, 7 days, and
      6 weeks after sacrospinous ligament fixation with a new device, the Anchorsure® Suture
      Anchoring System (Neomedic) compared to the widely utilized Capio™ Slim (Boston Scientific)
      device. 60 patients will be enrolled to undergo sacrospinous ligament fixation for treatment
      of pelvic organ prolapse. The patients will be randomized into two study groups; one will
      have sacrospinous ligament fixation using the Capio™ Slim device and the other with the
      Anchorsure® device. The patient's pain will be recorded via the numerical rating scale (NRS),
      a validated pain evaluation tool. The study is powered to detect a 2.5 point difference in
      pain between the two groups, a value that has been shown in studies to be clinically
      significant to acute pain patients. Secondary outcomes of surgeon satisfaction and efficiency
      with the devices will be assessed via surgeon questionnaires.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 29, 2018</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants and research staff will be masked during the study as much as possible, however there will be a description of the type of sacrospinous ligament fixation device used within the body of the operative note for each patient that research staff could gain access to</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Buttock and Posterior Thigh Pain</measure>
    <time_frame>postoperative day 1, 7, and week 6</time_frame>
    <description>This will be assessed using the numeric rating scale (NRS). The score is 0-10, with higher scores denoting a greater degree of pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical Anatomic Success</measure>
    <time_frame>at week 6</time_frame>
    <description>POP-Q assessment will be performed with surgical success being defined as apical descent less than 50% of total vaginal length.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon satisfaction</measure>
    <time_frame>postoperative day 0</time_frame>
    <description>Surgeon satisfaction with application of surgical device will be assessed via a 5-point rating scale (very dissatisfied, somewhat dissatisfied, neutral, satisfied, very satisfied).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical efficiency</measure>
    <time_frame>intraoperative</time_frame>
    <description>Surgical efficiency will be assessed as continuous data measured as a means in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic success- PFDI-20</measure>
    <time_frame>at week 6 postoperative</time_frame>
    <description>Symptomatic success will be assessed by the pelvic floor disability index (PFDI-20) questionnaire. The PFDI-20 has 20 items within 3 scales of symptoms (total of 20 items). Each item produces a response of 0 to 4, the average response in each scale is multiplied by 25 to obtain the scale score (range 0 to 100). The total score is the sum of the three scale score with a range of 0-300. Higher values indicate a greater degree of bother.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic success- PFIQ-7</measure>
    <time_frame>at week 6 postoperative</time_frame>
    <description>Symptomatic success will be assessed by the pelvic floor impact (PFIQ-7) questionnaire. The PFIQ-7 has 7 items for each of 3 scales (total of 21 items). Each item produces a response of 0 to 3, the average response in each scale is multiplied by 100/3 to obtain the scale score (range 0 to 100). The total score is the sum of the three scale score with a range of 0-300. Higher values indicate a greater degree of bother.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Postoperative general pelvic pain</measure>
    <time_frame>postoperative day 1, 7, and week 6</time_frame>
    <description>This will be assessed using the numeric rating scale (NRS). The score is 0-10, with higher scores denoting a greater degree of pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative post-hospitalization opioid use</measure>
    <time_frame>postoperative day 7</time_frame>
    <description>Patients will be given a diary to record the amount of opioid pain medications they use at home after their procedure until day 7. The cumulative dose of pain medication will be converted into morphine equivalents for analysis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Capio Slim Device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be randomized to the sacrospinous ligament fixation with use of Capio Slim Device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anchorsure Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be randomized to the sacrospinous ligament fixation with use of Anchorsure Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Capio Slim Device</intervention_name>
    <description>Participants who have been assigned to sacrospinous ligament fixation for pelvic organ prolapse will have sacrospinous ligament fixation performed with the Capio Slim Device.</description>
    <arm_group_label>Capio Slim Device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anchorsure Device</intervention_name>
    <description>Participants who have been assigned to sacrospinous ligament fixation for pelvic organ prolapse will have sacrospinous ligament fixation performed with the Anchorsure Device.</description>
    <arm_group_label>Anchorsure Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients

          -  At least 21 years of age

          -  Surgical plan that includes a native tissue vaginal repair with apical support via
             sacrospinous ligament fixation. We will permit both hysteropexy and post-hysterectomy
             sacrospinous ligament suspension

          -  Understanding and acceptance of the need to return for the 6 week follow-up visit

          -  English speaking and able to give informed consent

          -  Willing and able to complete all study questionnaires

          -  Ambulatory

        Exclusion Criteria:

          -  Prior sacrospinous ligament fixation procedure.

          -  Any serious disease or chronic condition that could interfere with the study
             compliance

          -  Inability to give informed consent

          -  Pregnancy or planning pregnancy prior to the 6 week postoperative visit

          -  Prior pelvic radiation

          -  Incarcerated

          -  Prior augmented (synthetic mesh, autologous graft, xenograft, allograft) prolapse
             repair

          -  History of significant buttock or leg pain in the past 3 months

          -  History of fibromyalgia, polymyositis, dermatomyositis, systemic lupus erythematosus,
             or other auto-immune myalgic conditions

          -  Current regular opioid drug therapy for any chronic pain condition

          -  History of loss of motor or sensory function of the lower extremities

          -  History of sacral decubitus ulcers

          -  Planned concomitant levatorplasty; anal sphincteroplasty, anal fissurectomy,
             rectopexy, or hemorrhoidectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Must have biological female reproductive organs.</gender_description>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Matthews, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andre R Plair, MD</last_name>
    <phone>336-716-4310</phone>
    <email>aplair@wakehealth.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Catherine Matthews, MD</last_name>
    <email>camatthe@wakehealth.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andre R Plair, MD</last_name>
      <phone>336-716-4310</phone>
      <email>aplair@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Catherine Matthews, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/UCM262760.pdf</url>
    <description>FDA 2011 Urogynecologic Surgical Mesh: Update on the Safety and Effectiveness of Transvaginal Placement for Pelvic Organ Prolapse</description>
  </link>
  <link>
    <url>https://www.ics.org/2017/abstract/850</url>
    <description>SOUSA A, FLORES J, LEON J, SOUSA-GONZALEZ D. ICS 2017 Annual Meeting, Florence. Non-Discussion Video #850: RESULTS OF EFFICIENCY AND SAFETY IN REPAIRING PREVIOUS PROLAPSE THROUGH THE SURELIFT® SYSTEM. 5 YEARS RESULTS</description>
  </link>
  <link>
    <url>https://www.ics.org/2010/abstract/864</url>
    <description>AMAT L, GOMEZ A, MARTINEZ E, KAPLAN E. ICS 2010 Annual Meeting, Toronto. Non-Discussion Video #864: EVALUATION OF THE SAFETY AND EFFICACY OF PELVIC ORGAN PROLAPSE REPAIR USING SURELIFT® SYSTEM - PRELIMINARY RESULTS</description>
  </link>
  <link>
    <url>https://academy.iuga.org/iuga/2015/40th/142097/xinxin.lin.surgical.treatment.of.genital.prolapse.with.surelift.mesh.in.html</url>
    <description>LIN X, et al. 2015 IUGA Annual Meeting, Nice. Non-Discussed Poster #NDP310: SURGICAL TREATMENT OF GENITAL PROLAPSE WITH SURELIFT® MESH IN PATIENTS AT RISK OF RECURRENCE</description>
  </link>
  <link>
    <url>https://academy.iuga.org/iuga/2015/40th/141775/eugene.kaplan.anchorsure.-.anchoring.system.outcomes.and.safety.profile.in.html?f=topic=13720*media=3</url>
    <description>KAPLAN E. 2015 IUGA Annual Meeting, NICE. Non-Discussed Poster #NDP295: ANCHORSURE - ANCHORING SYSTEM: OUTCOMES AND SAFETY PROFILE IN VAGINAL RECONSTRUCTIVE SURGERY</description>
  </link>
  <link>
    <url>https://iugameeting.org/program/</url>
    <description>Salicrú S. 2018 IUGA Annual Meeting, Vienna. Unmoderated Poster #503: Surgical repair of severe prolapse with Surelift System</description>
  </link>
  <reference>
    <citation>Barber MD, Chen Z, Lukacz E, Markland A, Wai C, Brubaker L, Nygaard I, Weidner A, Janz NK, Spino C. Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn. 2011 Apr;30(4):541-6. doi: 10.1002/nau.20934. Epub 2011 Feb 22.</citation>
    <PMID>21344495</PMID>
  </reference>
  <reference>
    <citation>Atherton MJ, Daborn JP, Tsokos N, Jeffery JT, Yin MJ. Complications associated with tissue anchor migration after vaginal surgery using the tissue fixation system - a case series. Aust N Z J Obstet Gynaecol. 2012 Feb;52(1):83-6. doi: 10.1111/j.1479-828X.2011.01383.x. Epub 2011 Dec 6.</citation>
    <PMID>22141331</PMID>
  </reference>
  <reference>
    <citation>Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005 Jul;193(1):103-13.</citation>
    <PMID>16021067</PMID>
  </reference>
  <reference>
    <citation>Brennand EA, Bhayana D, Tang S, Birch C, Murphy M, Cenaiko D, Ross S, Robert M. Anchor placement and subsequent movement in a mesh kit with self-fixating tips: 6-month follow-up of a prospective cohort. BJOG. 2014 Apr;121(5):634-40. doi: 10.1111/1471-0528.12536. Epub 2014 Jan 13.</citation>
    <PMID>24621073</PMID>
  </reference>
  <reference>
    <citation>Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996 Jul;175(1):10-7.</citation>
    <PMID>8694033</PMID>
  </reference>
  <reference>
    <citation>Cepeda MS, Africano JM, Polo R, Alcala R, Carr DB. What decline in pain intensity is meaningful to patients with acute pain? Pain. 2003 Sep;105(1-2):151-7.</citation>
    <PMID>14499431</PMID>
  </reference>
  <reference>
    <citation>DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol. 1992 Jun;166(6 Pt 1):1717-24; discussion 1724-8.</citation>
    <PMID>1615980</PMID>
  </reference>
  <reference>
    <citation>Eilber KS, Alperin M, Khan A, Wu N, Pashos CL, Clemens JQ, Anger JT. Outcomes of vaginal prolapse surgery among female Medicare beneficiaries: the role of apical support. Obstet Gynecol. 2013 Nov;122(5):981-7. doi: 10.1097/AOG.0b013e3182a8a5e4.</citation>
    <PMID>24104778</PMID>
  </reference>
  <reference>
    <citation>Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage. 2003 May;25(5):406-11.</citation>
    <PMID>12727037</PMID>
  </reference>
  <reference>
    <citation>Ferrando CA, Walters MD. A randomized double-blind placebo-controlled trial on the effect of local analgesia on postoperative gluteal pain in patients undergoing sacrospinous ligament colpopexy. Am J Obstet Gynecol. 2018 Jun;218(6):599.e1-599.e8. doi: 10.1016/j.ajog.2018.03.033. Epub 2018 Mar 31.</citation>
    <PMID>29614274</PMID>
  </reference>
  <reference>
    <citation>Haefeli M, Elfering A. Pain assessment. Eur Spine J. 2006 Jan;15 Suppl 1:S17-24. Epub 2005 Dec 1. Review.</citation>
    <PMID>16320034</PMID>
  </reference>
  <reference>
    <citation>Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S; European Palliative Care Research Collaborative (EPCRC). Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011 Jun;41(6):1073-93. doi: 10.1016/j.jpainsymman.2010.08.016. Review.</citation>
    <PMID>21621130</PMID>
  </reference>
  <reference>
    <citation>Hsu Y, Chen L, Summers A, Ashton-Miller JA, DeLancey JO. Anterior vaginal wall length and degree of anterior compartment prolapse seen on dynamic MRI. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jan;19(1):137-42. Epub 2007 Jun 20. Erratum in: Int Urogynecol J Pelvic Floor Dysfunct. 2014 Oct;25(10):1447. DeLancey, James O L [corrected to DeLancey, John O L].</citation>
    <PMID>17579801</PMID>
  </reference>
  <reference>
    <citation>Inoue H, Sekiguchi Y, Kohata Y, Satono Y, Hishikawa K, Tominaga T, Oobayashi M. Tissue fixation system (TFS) to repair uterovaginal prolapse with uterine preservation: a preliminary report on perioperative complications and safety. J Obstet Gynaecol Res. 2009 Apr;35(2):346-53.</citation>
    <PMID>19708181</PMID>
  </reference>
  <reference>
    <citation>Karacaoglu MU, Ozyurek ES, Mutlu S, Odacilar E. Unilateral sacrospinous ligament fixation (USLF) with a mesh stabilizing anchor set: clinical outcome and impact on quality of life. Clin Exp Obstet Gynecol. 2016;43(2):216-9.</citation>
    <PMID>27132413</PMID>
  </reference>
  <reference>
    <citation>Maher CF, Murray CJ, Carey MP, Dwyer PL, Ugoni AM. Iliococcygeus or sacrospinous fixation for vaginal vault prolapse. Obstet Gynecol. 2001 Jul;98(1):40-4.</citation>
    <PMID>11430954</PMID>
  </reference>
  <reference>
    <citation>Mowat A, Wong V, Goh J, Krause H, Pelecanos A, Higgs P. A descriptive study on the efficacy and complications of the Capio (Boston Scientific) suturing device for sacrospinous ligament fixation. Aust N Z J Obstet Gynaecol. 2018 Feb;58(1):119-124. doi: 10.1111/ajo.12720. Epub 2017 Sep 22.</citation>
    <PMID>28940223</PMID>
  </reference>
  <reference>
    <citation>Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010 Nov;116(5):1096-100. doi: 10.1097/AOG.0b013e3181f73729.</citation>
    <PMID>20966694</PMID>
  </reference>
  <reference>
    <citation>Stanford EJ, Moore RD, Roovers JP, Courtieu C, Lukban JC, Bataller E, Liedl B, Sutherland SE. Elevate anterior/apical: 12-month data showing safety and efficacy in surgical treatment of pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2013 Mar-Apr;19(2):79-83. doi: 10.1097/SPV.0b013e318278cc29.</citation>
    <PMID>23442504</PMID>
  </reference>
  <reference>
    <citation>Summers A, Winkel LA, Hussain HK, DeLancey JO. The relationship between anterior and apical compartment support. Am J Obstet Gynecol. 2006 May;194(5):1438-43. Epub 2006 Mar 30.</citation>
    <PMID>16579933</PMID>
  </reference>
  <reference>
    <citation>Unger CA, Walters MD. Gluteal and posterior thigh pain in the postoperative period and the need for intervention after sacrospinous ligament colpopexy. Female Pelvic Med Reconstr Surg. 2014 Jul-Aug;20(4):208-11. doi: 10.1097/SPV.0000000000000091.</citation>
    <PMID>24978086</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>June 11, 2018</study_first_submitted>
  <study_first_submitted_qc>June 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2018</study_first_posted>
  <last_update_submitted>May 19, 2020</last_update_submitted>
  <last_update_submitted_qc>May 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Buttock pain</keyword>
  <keyword>Thigh pain</keyword>
  <keyword>Sacrospinous ligament fixation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-Identified data from the study will be kept on password protected digital storage for at least three years following the project completion.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>At least 3 years from study completion</ipd_time_frame>
    <ipd_access_criteria>Contact the principal investigator (Dr. Catherine Matthews) or project manager (Dr. Andre Plair)</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

